Janux Therapeutics, Inc. (JANX)

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.

Address

10955 VISTA SORRENTO PARKWAY
SAN DIEGO, CA 92130

Founded

2017

Number of Employees

64